Market Tracker

09/22 5:48am ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

16.60
Delayed Data
As of Sep 21
 -0.08 / -0.48%
Today’s Change
8.18
Today|||52-Week Range
17.55
+68.02%
Year-to-Date

Today’s Trading

Previous close16.68
Today’s open16.60
Day’s range16.31 - 16.77
Volume1,180,380
Average volume (3 months)1,316,419
Market cap$2.4B
Dividend yield--
Data as of 09/21/2017

Growth & Valuation

Earnings growth (last year)-224.00%
Earnings growth (this year)+73.11%
Earnings growth (next 5 years)+11.83%
Revenue growth (last year)+8.61%
P/E ratioNM
Price/Sales8.62
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc+0.29+0.84%
BPMCBlueprint Medicines ...+0.60+0.97%
XLRNAcceleron Pharma Inc-2.68-7.10%
XONIntrexon Corp-0.14-0.74%
Data as of 09/21/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$146.7M
Annual profit (last year)-$103.0M
Net profit margin-70.23%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts